Caplight Directory>Investors>Viva Biotech>Viva-biotech-hkg-01873


Viva Biotech

Viva Biotech

Shanghaivivabiotech.com

Overview

Viva Biotech Holdings is a publicly-traded contract research and manufacturing company that also operates as an investor, primarily through its Viva BioInnovator division, which supports early-stage biotech companies with cash investments and an 'Equity-for-Service' (EFS) model.

Year Founded

2008

Portfolio Companies

13

Investments

CompanyDateStageLead
HAYA TherapeuticsMay 2025Series A-
Antag TherapeuticsDec 2024Series A-
Full-Life Technologies|HomeJan 2024Series B-
Mediar TherapeuticsMar 2023Series A-
VivaVision BiotechApr 2021Series D-
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai
Year Founded2008

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.